Optimizing methotrexate withdrawal during COVID vaccination

Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.

Detalles Bibliográficos
Autor principal: McHugh, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524381/
https://www.ncbi.nlm.nih.gov/pubmed/36180548
http://dx.doi.org/10.1038/s41584-022-00856-7
Descripción
Sumario:Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.

Ejemplares similares